News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
FDA
Astellas Pharma Inc. Wins Japan Approval for New Transplant Drug
July 17, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TOKYO, July 17 (Reuters) - Astellas Pharma Inc said on Thursday it had won approval to sell a new version of its key transplant drug in Japan, the second major region where it has gained approval although it is facing delays in the United States.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Asia
Astellas Pharma US, Inc.
MORE ON THIS TOPIC
GLP-1
Lilly Wins Court Battle Against Compounders as Judge Backs FDA: Tirzepatide No Longer in Shortage
May 8, 2025
·
2 min read
·
Tristan Manalac
Vaccines
FDA Vaccine Advisors To Meet for COVID-19 Vaccine Updates
May 8, 2025
·
2 min read
·
Tristan Manalac
FDA
Vinay Prasad’s FDA Appointment ‘Anything but Status Quo’
May 8, 2025
·
4 min read
·
Dan Samorodnitsky
Job Trends
Recent Federal Actions Put US, Massachusetts Biotech Leadership at Risk: MassBio
May 7, 2025
·
3 min read
·
Angela Gabriel